London: British pharma giant AstraZeneca is contemplating combining its COVID-19 vaccine with Russian Sputnik V vaccine in a bid to increase efficacy.
AstraZeneca said on Friday it will be assessing combinations of their vaccine with the one developed by Russia’s Gamaleya Institute.
Both vaccines are based on the common cold virus.
“Current full dose AstraZeneca regimen resulted in 62% efficacy. If they go for a new clinical trial, we suggest trying a regimen of combining the AZ shot with the #SputnikV human adenoviral vector shot to boost efficacy. Combining vaccines may prove important for revaccinations,” the developers of Sputnik V had said last month.
The Oxford-AstraZeneca vaccine has an average efficacy of 70.4 per cent, while Russia has claimed a 92 per cent effectiveness for its Sputnik V.
Also Read: Govt Likely To Get Oxford COVID Vaccine In January-February
New Delhi: After Diljit Dosanjh called out the double standards of Telangana government for banning…
New Delhi: Recent actions and counter-actions in the Russia-Ukraine conflict have pushed the world to the…
Balangir: Three persons were arrested and fake IPS officers’ uniforms along with fake identity cards…
Mumbai: Abhishek Bachchan’s highly-anticipated film ‘I Want To Talk’ released in theatres on Friday, and the…
New Delhi: Accused of giving cash to secure votes ahead of election day in Maharashtra,…
Bhubaneswar: Chief Minister Mohan Charan Majhi attended the ‘Odisha State Day Celebrations’ at the 43rd…
Mumbai: Recently, some morphed pictures of actress Shweta Tiwari and her good friend Vishal Aditya…
Phulbani: Two tribal men were sentenced to life imprisonment by a special court in Odisha's…